452 related articles for article (PubMed ID: 36856339)
1. COVID-19 and its long-term impact on the cardiovascular system.
Philip B; Mukherjee P; Khare Y; Ramesh P; Zaidi S; Sabry H; Harky A
Expert Rev Cardiovasc Ther; 2023 Mar; 21(3):211-218. PubMed ID: 36856339
[TBL] [Abstract][Full Text] [Related]
2. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
Chang X; Ismail NI; Rahman A; Xu D; Chan RWY; Ong SG; Ong SB
Antioxid Redox Signal; 2023 Mar; 38(7-9):599-618. PubMed ID: 36053670
[No Abstract] [Full Text] [Related]
3. Cardiac Involvement of COVID-19: A Comprehensive Review.
Chang WT; Toh HS; Liao CT; Yu WL
Am J Med Sci; 2021 Jan; 361(1):14-22. PubMed ID: 33187633
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
Aleksova A; Fluca AL; Gagno G; Pierri A; Padoan L; Derin A; Moretti R; Noveska EA; Azzalini E; D'Errico S; Beltrami AP; Zumla A; Ippolito G; Sinagra G; Janjusevic M
Life Sci; 2022 Dec; 310():121018. PubMed ID: 36183780
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
[TBL] [Abstract][Full Text] [Related]
6. COVID and Cardiovascular Disease: What We Know in 2021.
Chilazi M; Duffy EY; Thakkar A; Michos ED
Curr Atheroscler Rep; 2021 May; 23(7):37. PubMed ID: 33983522
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician.
Tobler DL; Pruzansky AJ; Naderi S; Ambrosy AP; Slade JJ
Curr Atheroscler Rep; 2022 Jul; 24(7):563-570. PubMed ID: 35507278
[TBL] [Abstract][Full Text] [Related]
8. Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes.
Parhizgar P; Yazdankhah N; Rzepka AM; Chung KYC; Ali I; Lai Fat Fur R; Russell V; Cheung AM
Can J Cardiol; 2023 Jun; 39(6):726-740. PubMed ID: 36754119
[TBL] [Abstract][Full Text] [Related]
9. [Pathophysiological basis and diagnosis of the cardiovascular system damage caused by coronavirus infection].
Serezhina EK; Obrezan AG
Kardiologiia; 2022 Mar; 62(3):82-88. PubMed ID: 35414365
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
Abdel Moneim A; Radwan MA; Yousef AI
Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations.
Wang RS; Loscalzo J
Circ Res; 2023 May; 132(10):1374-1386. PubMed ID: 37167362
[TBL] [Abstract][Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Complications of Coronavirus Disease-2019.
Terzic CM; Medina-Inojosa BJ
Phys Med Rehabil Clin N Am; 2023 Aug; 34(3):551-561. PubMed ID: 37419531
[TBL] [Abstract][Full Text] [Related]
14. Can adverse cardiac events of the COVID-19 vaccine exacerbate preexisting diseases?
Razzaque MS
Expert Rev Anti Infect Ther; 2024 Apr; 22(4):131-137. PubMed ID: 38284355
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges.
Shah KS; Hale Hammond ME; Drakos SG; Anderson JL; Fang JC; Knowlton KU; Shaw RM
Future Cardiol; 2021 Oct; 17(7):1277-1291. PubMed ID: 33739142
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
Ogah OS; Umuerri EM; Adebiyi A; Orimolade OA; Sani MU; Ojji DB; Mbakwem AC; Stewart S; Sliwa K
Glob Heart; 2021 Mar; 16(1):18. PubMed ID: 33833942
[TBL] [Abstract][Full Text] [Related]
17. Long COVID and its cardiovascular consequences: What is known?
Składanek JA; Leśkiewicz M; Gumiężna K; Baruś P; Piasecki A; Klimczak-Tomaniak D; Sygitowicz G; Kochman J; Grabowski M; Tomaniak M
Adv Clin Exp Med; 2024 Mar; 33(3):299-308. PubMed ID: 37386857
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2.
Lawal IO; Kgatle MM; Mokoala K; Farate A; Sathekge MM
BMC Cardiovasc Disord; 2022 Mar; 22(1):93. PubMed ID: 35264107
[TBL] [Abstract][Full Text] [Related]
20. Cell-Specific Mechanisms in the Heart of COVID-19 Patients.
Tsai EJ; Cˇiháková D; Tucker NR
Circ Res; 2023 May; 132(10):1290-1301. PubMed ID: 37167361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
